ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma
Clinical trial NCT07021989 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07021989
- Sponsor
- Michael Spinner, MD
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-10-01
- Primary completion
- 2029-07-31
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.